GTC Biotherapeutics Licenses Recombinant Fibrinogen Patents to ... - Business Wire (press release)

GTC Biotherapeutics Licenses Recombinant Fibrinogen Patents to ... Business Wire (press release), CA - 7 hours ago GTC’s intellectual property includes a patent in the United States through 2021 for the production of any therapeutic protein in the milk of any transgenic ...

Source: http://news.google.com/news/url?sa=T&ct=us/8-0&fd=R&url=http://www.businesswire.com/news/google/20080625005615/en&cid=1224222915&ei=7qRiSOqlGJauyAS55aSmDQ&usg=AFQjCNFcBNLxA8dTrLl9xajQZ5T48igZyA